Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- VITAL-NET, KSK to Merge to Create 5th Largest Drug Wholesaler
December 1, 2008
- R&D NEWS IN BRIEF
December 1, 2008
- Korosho to Press Large Hospitals to Settle Prices by Year-End
December 1, 2008
- Japan Needs NHI Pricing System That Encourages Innovation: Mr Kinoshita
December 1, 2008
- Advent of Wholesaler Behemoth Will Induce Power Shift
December 1, 2008
- REGULATORY NEWS IN BRIEF
December 1, 2008
- Matsumotokiyoshi to Provide Dispensing Services at 200 Stores
December 1, 2008
- JODA Introduces GL for Online Sales of OTC Drugs
December 1, 2008
- Asahi Kasei Obtains All Rights Related to Naftopidil from Roche Diagnostics
December 1, 2008
- Groups Present Petition Calling For Ban of Online Sales of Drugs
December 1, 2008
- EPS: CRO Business Props Up 19.2% Growth in Sales
December 1, 2008
- Final Draft GL Published for HRT
December 1, 2008
- BUSINESS NEWS IN BRIEF
December 1, 2008
- SELF-MEDICATION NEWS IN BRIEF
December 1, 2008
- Nichi-Iko to Overtake Taiyo to Become 2nd Largest Generic House, Following Sawai
December 1, 2008
- Pfizer to Perform Study in Japanese Patients to Strengthen Evidence for Selara
December 1, 2008
- Sawai: Sales Up 18% with Good Sales of New Products
December 1, 2008
- Nihon Chouzai: Investment in Generics Business Depresses Profitability
November 24, 2008
- Ajinomoto: Pharma Sales Up 1.0% to \42.9 Bil.
November 24, 2008
- QOL: Acquisition Boosts Sales by 52%
November 24, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…